TY - JOUR
T1 - Interstitial lung abnormalities detected incidentally on CT
T2 - a Position Paper from the Fleischner Society
AU - Hatabu, Hiroto
AU - Hunninghake, Gary M.
AU - Richeldi, Luca
AU - Brown, Kevin K.
AU - Wells, Athol U.
AU - Remy-Jardin, Martine
AU - Verschakelen, Johny
AU - Nicholson, Andrew G.
AU - Beasley, Mary B.
AU - Christiani, David C.
AU - San José Estépar, Raúl
AU - Seo, Joon Beom
AU - Johkoh, Takeshi
AU - Sverzellati, Nicola
AU - Ryerson, Christopher J.
AU - Graham Barr, R.
AU - Goo, Jin Mo
AU - Austin, John H.M.
AU - Powell, Charles A.
AU - Lee, Kyung Soo
AU - Inoue, Yoshikazu
AU - Lynch, David A.
N1 - Publisher Copyright:
© 2020 Elsevier Ltd
PY - 2020/7
Y1 - 2020/7
N2 - The term interstitial lung abnormalities refers to specific CT findings that are potentially compatible with interstitial lung disease in patients without clinical suspicion of the disease. Interstitial lung abnormalities are increasingly recognised as a common feature on CT of the lung in older individuals, occurring in 4–9% of smokers and 2–7% of non-smokers. Identification of interstitial lung abnormalities will increase with implementation of lung cancer screening, along with increased use of CT for other diagnostic purposes. These abnormalities are associated with radiological progression, increased mortality, and the risk of complications from medical interventions, such as chemotherapy and surgery. Management requires distinguishing interstitial lung abnormalities that represent clinically significant interstitial lung disease from those that are subclinical. In particular, it is important to identify the subpleural fibrotic subtype, which is more likely to progress and to be associated with mortality. This multidisciplinary Position Paper by the Fleischner Society addresses important issues regarding interstitial lung abnormalities, including standardisation of the definition and terminology; predisposing risk factors; clinical outcomes; options for initial evaluation, monitoring, and management; the role of quantitative evaluation; and future research needs.
AB - The term interstitial lung abnormalities refers to specific CT findings that are potentially compatible with interstitial lung disease in patients without clinical suspicion of the disease. Interstitial lung abnormalities are increasingly recognised as a common feature on CT of the lung in older individuals, occurring in 4–9% of smokers and 2–7% of non-smokers. Identification of interstitial lung abnormalities will increase with implementation of lung cancer screening, along with increased use of CT for other diagnostic purposes. These abnormalities are associated with radiological progression, increased mortality, and the risk of complications from medical interventions, such as chemotherapy and surgery. Management requires distinguishing interstitial lung abnormalities that represent clinically significant interstitial lung disease from those that are subclinical. In particular, it is important to identify the subpleural fibrotic subtype, which is more likely to progress and to be associated with mortality. This multidisciplinary Position Paper by the Fleischner Society addresses important issues regarding interstitial lung abnormalities, including standardisation of the definition and terminology; predisposing risk factors; clinical outcomes; options for initial evaluation, monitoring, and management; the role of quantitative evaluation; and future research needs.
UR - http://www.scopus.com/inward/record.url?scp=85087509290&partnerID=8YFLogxK
U2 - 10.1016/S2213-2600(20)30168-5
DO - 10.1016/S2213-2600(20)30168-5
M3 - Review article
C2 - 32649920
AN - SCOPUS:85087509290
SN - 2213-2600
VL - 8
SP - 726
EP - 737
JO - The Lancet Respiratory Medicine
JF - The Lancet Respiratory Medicine
IS - 7
ER -